CAS: 49561-96-8; 4-(Trifluoromethoxy)Phenylacetonitrile

该化合物是一种有机化合物,其特点是存在一个以三氟甲基苯氧基和丙烯三联苯三联苯基组和丙烯三联功能组替代的苯环,该化合物一般显示白色与白色外的固体外观,以其在水中的溶解性相对较低而闻名,同时在乙酮和二氯甲烷等有机溶剂中更易溶解.三氟氧基组有助于其独特的电子特性,加强其在各种化学反应中,特别是在合成药物和农用化学物时的再活性和潜在应用.此外,丙烯硝基苯丙烯三联苯三联苯三联苯可影响其极性和与生物系统的相互作用.与许多氟化合物一样,它可能具有明显的特性,例如稳定性和脂度较高.在处理和使用时,应当参考安全数据,因为氟化合物可能对环境和健康造成危害.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号773837-37-9 sodium cyanide | CAS号50824-05-0 对三氟甲氧基溴苄 | CAS号151-50-8 氰化钾 | CAS号1736-74-9 4-(三氟甲氧基)苄醇 | CAS号587-18-8 4-(三氟甲氧基)苯甲酸乙酯 | CAS号4315-07-5 4-(三氟甲氧基)苯基乙酸 | CAS号170015-99-3 4-三氟甲氧基苯乙胺 | CAS号936727-93-4 1-(4-Trifluorom...

合成工艺路线路线简述

    4-三氟甲氧基溴苄 以 乙醇,水 作为反应溶剂,以76.3%的收率获得产物4-(三氟甲氧基)苯基乙腈
    参考文献:Process For Preparing 2-(4-Trifluoromethoxyphenyl)Ethylamine And 4-Bromomethyl-And 4-Chloromethyl-1-Trifluoromethoxybenzene
    标题:Process For Preparing 2-(4-Trifluoromethoxyphenyl)Ethylamine And 4-Bromomethyl-And 4-Chloromethyl-1-Trifluoromethoxybenzene
    摘要:该发明涉及一种制备2-(4-三氟甲氧基苯基)乙胺的方法,通过以下步骤实现:(A) 将三氟甲氧基苯转化为卤甲基化合物,得到卤代甲基-1-三氟甲氧基苯;(B) 将卤代甲基-1-三氟甲氧基苯通过卤-氰交换反应转化为4-(三氟甲氧基苯基)乙腈;(C) 在镍催化剂存在下,使用氢气还原4-(三氟甲氧基苯基)乙腈,得到2-(4-三氟甲氧基苯基)乙胺.该方法的第一步也是制备4-溴甲基和4-氯甲基-1-三氟甲氧基苯的优势方法.

    海关参考信息

    专利信息


    专利号:US-4822903-A
    优先权日:1981-05-15
    标题:Fluorinated silica catalyst and preparation of aromatic/aliphatic nitriles in the presence thereof
    发明人:JACQUES ROLAND; REPPELIN MICHEL; SEIGNEURIN LAURENT
    权利人:RHONE POULENC SPEC CHIM
    摘要:An improved fluorinated siliceous catalyst, well adapted for the catalytic synthesis of aromatic/aliphatic nitriles from their corresponding formamides, formanilides or amides, is comprised of a plurality of silica particulates, the specific surface of which ranging from about 200 to about 300 m 2 /g, having a total pore volume ranging from about 1 to about 1.5 cm 3 /g, with an average pore diameter ranging from about 100 to about 200 â„«, having an exchange pH of less than about 3, and with the fluorine content thereof bonded to the silica, expressed in F 31 , ranging from about 0.05 to about 2% by weight based upon the silica, and the sodium content thereof, expressed as Na 2 O, being less than about 1% by weight, also based upon the silica.

    专利号:US-7816375-B2
    优先权日:2000-09-11
    标 题 :Ligands for monoamine receptors and transporters, and methods of use thereof
    发明人:AQUILA BRIAN M; BANNISTER THOMAS D; CUNY GREGORY D; HAUSKE JAMES R; HOLLAND JOANNE M; PERSONS PAUL E; RADEKE HEIKE; WANG FENGJIANG; SHAO LIMING
    权利人:SEPRACOR INC
    摘要:One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian cellular receptors, including dopamine, serotonin, or norepinephrine transporters. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, schizophrenia, Parkinson's disease, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, and Tourette's syndrome. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds, and the screening of those libraries for biological activity, e.g., in assays based on dopamine transporters.

    专利号:WO-2021078995-A1
    优先权日:2019-10-25
    标 题 :Selective polypeptide synthesis stalling assay and compound
    发明人:STROUS GERARDUS JACOBUS ANTONIUS MARIA; MOL JAN ADRIANUS; VAN DER VELDEN LIEKE MARIE; KLUMPERMAN JUDITH; MAAS PETRUS EMMANUEL MARIE; PIET DENNIS PATRICK; DE KLERK-SPRENKELS NANDA ELISABETH; TIJHUIS JOHANN HEINRICH; VIÉTOR HENDRIK ENGELBERTUS; MAURICE MADELON MARIA; VAN DER KRIFT FELIX
    权利人:UMC UTRECHT HOLDING BV; UNIV UTRECHT HOLDING BV; BIMINI BIOTECH B V
    摘要:The invention relates to compounds, in particular pyrimidine-2,4-diamines, analogues and salts thereof and pharmaceutical compositions comprising pyrimidine-2,4-diamines analogues and salts thereof for use in the treatment and prevention of a disease, in particular a growth hormone receptor-dependent condition. The invention also relates to methods of using these compounds and compositions to treat physiological disorders related to the amount or activity of growth hormone. In a particular embodiment, the invention relates to a compound according to formula 1 for use in the treatment or prevention of a disease in a subject.

    专利号:US-7777060-B2
    优先权日:2007-02-14
    标题:Platinum analogs with bis-nitrile-containing ligands
    发明人:CHEN XINGHAI; PETLURU PAVANKUMAR N V; HUANG QIULI; NARKUNAN KESAVARAM; HAUSHEER FREDERICK
    权利人:BIONUMERIK PHARMACEUTICALS INC
    摘要:Disclosed herein are novel platinum-based analogs possessing two nitrile substituent groups (bis-nitrile) covalently-bonded to the platinum. Also disclosed herein are the reaction schemes for the synthesis of said platinum complexes, as well as quantitative in vitro IC50 data.

    专利号:RU-2122999-C1
    优先权日:1991-12-23
    标 题:Tetrahydroisoquinoline compounds or their pharmaceutically acceptable salts, method of their synthesis, pharmaceutical composition based on thereof and method of dophamine receptor binding
    丹阳瑞青化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.dyrqchem.com
    企业联系电话:0511-86913683👤
    📞丹阳瑞青化工有限公司 ⚠️参考联系方式
    联系人:郭经理
    电话:0511-86913683
    手机:13052938681
    传真:0511-86572559
    邮箱:sales@dyrqchem.com
    通信地址: 江苏省丹阳市开发区吾悦广场B座2109
    邮编: 212300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省丹阳市开发区吾悦广场B座2109
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知